JEFO Innovation Ft Carson_Redacted.pdf

JUSTIFICATION FOR AN EXCEPTION TO FAIR OPPORTUNITY (JEFO)

INNOVATION ASSOCIATES, INC.

(ECAT SUSPENDED CART REFERENCE #: )

1. Defense Logistics Agency (DLA) Troop Support, Medical Supply Chain, Capital Equipment Division, is the contracting activity.

2. The action submitted for approval is a JEFO for the purchase and installation of one (1) pharmacy workflow and automation PharmASSIST Symphony System at Evans Army Community Hospital, Fort Carson, CO, to be purchased from Innovation Associates, Inc.’s (CAGE Code: 2N269) Patient Monitoring and Capital Equipment (PMCE) Program contract SPE2D1-19-D-0017, valid through July 23, 2024, with a possible 5-Year option extending the contract through July 22, 2029. Innovation’s administrative ECAT contract number is SPE2D1-19-D-7011 and is also current.

3. The purchase includes: server, workstation, signature capture pad, scanner, Windows 10, RxImage station, Symphony Software license Level 1, Integrated Medifacts Module (includes VucaHealth MedsOnQue license), and other software licenses, as well as shipping, installation and training. The estimated total of this acquisition is .

4. The authority waiving the competition requirements is FAR 16.505(b)(2)(i)(B), only one awardee is capable of providing the supplies or services required at the level of quality required because the supplies or services ordered are unique or highly specialized.

The Innovation PharmASSIST system is the only system that meets all of the requirements of the government. The PharmASSIST system utilizes the VucaHealth MedsOnQue software which allows for electronic delivery of Food & Drug Administration (FDA) medication guides and virtual education including videos for patients detailing their medications and how to properly use them. This license allows for Defense Health Agency (DHA) to comply with two federal mandates: Omnibus Budget Reconciliation Act of 1990 (OBRA 90) which requires pharmacies to provide an offering of patient counseling on all prescriptions and Code of Federal Regulations Title 21, Subpart B, which requires specific medications to be dispensed with a FDA Medication Guide. This system is the first and only system deployed that enables 100% FDA compliance.

Only one source, Innovation Associates Inc., is capable of supplying the PharmASSIST Symphony System, to include all software, licenses, workstations, and servers. The system is proprietary. Innovation Associates Inc. holds all copyrights to the PharmASSIST Symphony software and no other entity has the right to reengineer, modify, or provide technical support to this system. Any attempts to purchase third party equipment/software upgrades will void the extended warranty contract that DHA currently has in place. Furthermore, Innovation Associates is the only distributor for this item on DLA Patient Monitoring Capital Equipment Program, offered under contract SPE2D1-19-D-0017, this necessitates utilizing Innovation Associates as the sole-source provider.

5. Market research was conducted by the end user technical experts from December 2019 to February 2020.

This research consisted of a review of previous RFQs for similar requirements; requests for information to the industry for both enterprise workflow solutions and regional architecture; reviewing online catalogs and other generally available product literature published by the manufacturers, distributors, and dealers;

physically working with the current systems as all currently discussed vendors are in the DoD; attendance by multiple individuals of the market research team to multiple pharmacy and healthcare conferences

I have reviewed this justification and recommend approval.

DATE

Chief, Capital Equipment Division

I have reviewed this justification for legal sufficiency.

DATE

DLA Counsel – Troop Support